Literature DB >> 227928

Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.

J B Marsh, C E Sparks.   

Abstract

Livers from normal and nephrotic rats were perfused by the nonrecirculating technique. Nephrosis was studied on the 7th d after the injection of puromycin animonucleoside. Amino acid-labeled lipoproteins (d < 1.21) were isolated from the perfusion medium by agarose column chromatography or by sequential density ultracentrifugation. In both groups of animals, in addition to very low density lipoproteins and nascent high density lipoproteins, column chromatography revealed the presence of a peak of 2-3 x 10(6) daltons. This peak contained lipoproteins of densities corresponding to <1.006, 1.006 < d < 1.02, and 1.02 < d < 1.06, which indicated that rat liver secretes a heterogeneous mixture of triglyceride-rich lipoproteins. The amount of these lipoprotein density classes was measured and their lipid and apoprotein composition and their apoprotein specific activity were determined. In both groups of rats there was a progressive rise in phospholipid and decrease in triglyceride content as the isolation density increased from 1.006 and 1.06. The lipoproteins from the nephrotics had higher amounts of cholesterol. The livers from the nephrotic rats secreted two to three times as much lipoprotein as controls in all density classes in the first 20 min, but during the next 40 min only the 1.02 < d < 1.06 and nascent high density lipoproteins remained at this high level compared to controls. A larger total liver pool of apolipoproteins in nephrotic livers was inferred from their lower specific activities during the first 20 min. The apoprotein composition of liver perfusate lipoproteins from nephrotics differed from controls. There was a 40% decrease in the amount of low molecular weight apoproteins in all density classes, with corresponding increases in apo B and apo E in the triglyceride-rich fractions. The apo A-1 content of nascent HDL was increased from 16% in controls to 52% in nephrotics, with corresponding decreases in apo C and apo E. When these results were combined with specific activity measurements of the individual apoproteins and the net secretion rate of total protein in each lipoprotein class, it was possible to estimate the total amount of each apoprotein secreted and the total incorporation of labeled amino acids into each. The incorporation of label gave results similar to those obtained by direct measurement of the amounts of apoproteins. Apo E secretion was increased by a factor of 1.8, apo B by 2.8, and apo A-1 by 8.4, whereas the secretion of apo C was not significantly altered. We explain these results by postulating that the primary stimulus to hepatic plasma protein synthesis in response to proteinuria is general and that subsequent negative feedback regulation affects individual apolipoprotein synthesis rates. A corollary of this hypothesis is that the biosynthesis and secretion of an apoprotein may be regulated independently of the lipoprotein density class in which it is found.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227928      PMCID: PMC371268          DOI: 10.1172/JCI109577

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Metabolic channeling in experimental nephrosis. II. Lipide metabolism.

Authors:  J B MARSH; D L DRABKIN
Journal:  J Biol Chem       Date:  1955-02       Impact factor: 5.157

2.  Amino acid mobilization in plasma protein biosynthesis in experimental nephrosis.

Authors:  D L DRABKIN; J B MARSH; G A BRAUN
Journal:  Metabolism       Date:  1962-09       Impact factor: 8.694

3.  Studies on the synthesis and secretion of serum lipoproteins by rat liver slices.

Authors:  C M RADDING; D STEINBERG
Journal:  J Clin Invest       Date:  1960-10       Impact factor: 14.808

4.  Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia.

Authors:  J B MARSH; D L DRABKIN
Journal:  Metabolism       Date:  1960-10       Impact factor: 8.694

5.  Metabolic channeling in experimental nephrosis. III. Influence of diet and of adrenalectomy; liver hypertrophy.

Authors:  J B MARSH; D L DRABKIN
Journal:  J Biol Chem       Date:  1958-02       Impact factor: 5.157

6.  Evidence of intermediate compounds in serum albumin synthesis.

Authors:  T PETERS
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

7.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  Labeling of high density lipoproteins with [3H] acetic anhydride.

Authors:  J B Marsh
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

10.  Evidence that a separate particle containing B-apoprotein is present in high-density lipoproteins from perfused rat liver.

Authors:  M Fainaru; T E Felker; R L Hamilton; R J Havel
Journal:  Metabolism       Date:  1977-09       Impact factor: 8.694

View more
  10 in total

1.  Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes.

Authors:  J D Sparks; C E Sparks; L L Miller
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

2.  Serum and urine leptin concentration in children with nephrotic syndrome.

Authors:  Anna Wasilewska; Barbara Tomaszewska; Walentyna Zoch-Zwierz; Anna Biernacka; Krystyna Klewinowska; Alicja Koput
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

3.  Hepatic cholesterol metabolism in experimental nephrotic syndrome.

Authors:  A al-Shurbaji; E Humble; M Rudling; B Lindenthal; L Berglund
Journal:  Lipids       Date:  1998-02       Impact factor: 1.880

Review 4.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

5.  Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins.

Authors:  E Gherardi; M Messori; R Rozzi; S Calandra
Journal:  Lipids       Date:  1980-10       Impact factor: 1.880

6.  Catabolism of very low density lipoproteins in experimental nephrosis.

Authors:  D W Garber; B A Gottlieb; J B Marsh; C E Sparks
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

Review 7.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

8.  Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors.

Authors:  T Jensen; K Borch-Johnsen; A Kofoed-Enevoldsen; T Deckert
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

9.  Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes.

Authors:  J D Sparks; C E Sparks; M Bolognino; A M Roncone; T K Jackson; J M Amatruda
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease.

Authors:  Jin Hui Tang; Yu Wen; Fei Wu; Xiao Y Zhao; Mei X Zhang; Jie Mi; Katherine Cianflone
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.